We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Johnson and Johnson Acquires Developer of IVD Technologies

By HospiMedica staff writers
Posted on 26 Jun 2008
Johnson & Johnson Nordic AB (Sollentuna, Sweden), a Johnson & Johnson company, has acquired Amic (Uppsala, Sweden), a privately held developer of in vitro diagnostic (IVD) technologies for use in point-of-care (POC) and near-patient settings. More...
The company will pay approximately US$40 million during the second quarter of the year 2008 for the expenses of in-process research and development. Other terms of the transaction were not disclosed.

The acquisition will provide Ortho-Clinical Diagnostics, Inc., (Raritan, NJ, USA), a Johnson & Johnson company, with access to a high performance technology platform--currently in development--that complements its clinical laboratory, immunohematology, and donor screening businesses.

Amic was formed with the mission to develop and produce polymer microsystems. The company integrates different functions onto a single chip. The functions include nanofluidic and microfluidic channels, surface chemistry, electrical wave-guides and connectors, refractive and diffractive microoptics. It is developing technology that uses the chip-based microfluidic platform to enable fully quantitative, immunoassay tests in POC or near-patient settings. This next-generation technology represents an advance in an area of diagnostics where double-digit market growth is anticipated.

Ortho-Clinical Diagnostics provides in-vitro diagnostic products that give healthcare professionals worldwide the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type, and the right unit.


Related Links:
Johnson & Johnson Nordic AB
Amic
Ortho-Clinical Diagnostics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
POCT RT-qPCR Analyzer
BG-X6
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.